Clinical Trials Directory

Trials / Unknown

UnknownNCT00274339

Prevacid vs Lifestyle Modifications for the Treatment of LPR

A Comparison of Prevacid 30mg BID Plus Lifestyle Modifications Versus Lifestyle Modifications Alone for the Treatment of Laryngopharyngeal Reflux (LPR) in Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
135 (estimated)
Sponsor
Hodge, Kenneth M., M.D. · Individual
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate changes in scores on the Reflux Finding Score and Reflux Symptom Index over a 24 week period. To enroll subjects must score at least a 13 on the Reflux Symptom Index and at least a 5 on the Reflux Finding Score. All subjects will receive education on lifestyle modifications with a nutritionist and exercise trainer. All subjects will be expected to comply with lifestyle modifications for the entire study period of 24 weeks. Half of all subjects will receive Prevacid 30mg BID and half will receive placebo BID for 24 weeks. Subjects will have 4 office visits over 24 weeks and weekly contacts with the study staff to assess Reflux Symptom Index and any health or medication changes.

Detailed description

The results of studies evaluating PPI therapy versus lifestyle modifications for the treatment of LPR have not been conclusive. However, many of these studies were conducted at tertiary care centers. We will look at patients presenting with LPR symptoms in a community setting. All subjects will have an exam of their larynx via laryngoscopy at each of the 4 study visits (screening, week 6, week 12, and week 24). Based on exam findings, the physician will complete the Reflux Finding Score. The subjects will also complete the Reflux Symptom Index weekly to assess for changes in their symptoms. The statistical analysis of this study will include evaluating changes in the Reflux Finding Scores and Reflux Symptom Index scores over the 24 weeks of study participation.

Conditions

Interventions

TypeNameDescription
DRUGPrevacid 30mg BID
BEHAVIORALLifestyle changes of exercise and diet changes for weight loss and avoidance of reflux inducing foods.

Timeline

Start date
2005-12-01
Completion
2008-06-01
First posted
2006-01-10
Last updated
2007-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00274339. Inclusion in this directory is not an endorsement.